View More View Less
  • 1 KLE University, Nehru Nagar, Belagavi, Karnataka 590 010, India
Restricted access

Two different botanical sources, Eclipta alba and Wedelia calendulacea are used as “Bhringaraja” in the Ayurvedic s ystem o f medicine. In the present study, an effort has been made to evaluate different sources by using high-performance thin-layer chromatography (HPTLC) as an analytical tool. Wedelolactone, one of the primary constituents of these plants, was taken as the marker compound for the evaluation. An HPTLC method was developed and validated for the evaluation of different sources of “Bhringaraja”. The chromatographic system was developed using silica gel 60 F254 HPTLC plates with the mobile phase toluene–chloroform–ethyl alcohol–formic acid (5:4:1:0.5, v/v). Linearity was found between the concentration ranges of 80 to 280 ng spot−1 (R2: 0.9994), and limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.36 ng spot−1 and 1.09 ng spot−1. The study has shown the presence of wedelolactone at the concentration of 0.26% w/w and 0.05% w/w in E. alba and W. calendulacea, respectively, whereas it was absent in another closely related species, Wedelia trilobata. At the same time, all the three plants were subjected to evaluation of quality-control parameters as per the World Health Organization (WHO) guidelines. Certain parameters such as foaming index, total alkaloids, and total bitter principles were significantly different in the three plants. Hence, the present HPTLC method development, and the validation and evaluation of quality-control parameters would be helpful in the standardization of individual plants and their formulations.

  • [1]

    K. K. Hullatti , M. S. Sharada, Indian J. Pharm. Sci. 72 (2010) 3945.

  • [2]

    http://www.techno-preneur.net/technology/project-profiles/food/bhring. html.

  • [3]

    B. Vaidya , Some Controversial Drugs in Indian Medicine, Oriental Publication, New Delhi, 1982.

  • [4]

    Anonymous, The Ayurvedic Pharmacopoeia of India, Part I, Vol. II, Ministry of Health and Family Welfare, Department of Ayush Govt. of India, New Delhi, 2008.

  • [5]

    P. V. Neeraja , E. Margaret, IJCPR 2 (2012) 18897.

  • [6]

    W. T. Shiera , A. C. Shiera, W. Xieb, C. J. Mirochab, Toxicon 39 (2001) 14351438.

  • [7]

    H. S. Oh , R. C. Smart, Proc. Natl. Acad. Sci. USA 93 (1996) 1252512530.

  • [8]

    S. M. Wong , S. Antus, A. Gottsegen, B. Fessler, G. S. Rao, J. Sonnenbichler, H. Wagner, Arzneim. Forsch. 38 (1988) 661665.

  • [9]

    I. Nomani , A. Mazumder, G. S. Chakraborthy, Int. J. PharmTech Res. 5 (2013) 95764.

  • [10]

    C. P. Khare (ed.) , Indian Medicinal Plants, Springer-Verlag, Berlin/Heidelberg, 2007.

  • [11]

    N. Balekar , T. Nakpheng, T. Srichana, Chiang Mai J. Sci. 41 (2014) 590605.

  • [12]

    Y. Liu , L. Zhan, T. Liu, M. Cheng, X. Liu, J. Ethnopharmacol. 157 (2014) 206211.

  • [13]

    Y. Xia , J. Chen, Y. Cao, C. Xu, R. Li, Y. Pan, Eur. J. Pharmacol. 714 (2013) 105111.

  • [14]

    D. Manvar , M. Mishra, S. Kumar, V. N. Pandey, J. Ethnopharmacol. 144 (2012) 545554.

  • [15]

    P. Cos , A. J. Vlietinck, D. V. Berghe, L. Maes, J. Ethnopharmacol. 106 (2006) 290302.

  • [16]

    J. Bruneton , Pharmacognosy, Phytochemistry, Medicinal Plants, 2nd edn., Lavoisier Publishing Inc., Secaucus, NJ, 1999.

  • [17]

    Anonymous, Quality Control Methods for Medicinal Plants Materials, WHO, Geneva, 2011.

  • [18]

    P. Rashmin , P. Mrunali, D. Nitin, D. Nidhi, P. Bharat, J. Food Drug Anal. 20 (2012) 794804.

  • [19]

    G. A. Shabir , J. Chromatogr. A 987 (2003) 5766.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2020 0 0 0
Nov 2020 3 1 0
Dec 2020 1 0 0
Jan 2021 2 0 0
Feb 2021 3 0 0
Mar 2021 2 0 0
Apr 2021 0 0 0